Heron Therapeutics Inc (NASDAQ:HRTX)

33.89
Delayed Data
As of Jul 28
 +1.59 / +4.92%
Today’s Change
6.51
Today|||52-Week Range
36.81
+236.88%
Year-to-Date

Stock Price Forecast

The 6 analysts offering 12-month price forecasts for Heron Therapeutics Inc have a median target of 39.00, with a high estimate of 41.00 and a low estimate of 28.00. The median estimate represents a +15.08% increase from the last price of 33.89.

Analyst Recommendations

The current consensus among 6 polled investment analysts is to Buy stock in Heron Therapeutics Inc. This rating has held steady since July, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.65
Sales
$0.00
Reporting Date
Aug 07

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 6.90%
 
 
 
 
 
 
Growthannually 2.96%
 
 
 
 
 
 

Sales

Growthquarterly --
Growthannually --
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account